Study Evaluating the Etiology of Intra-Abdominal Infections
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer (Industry)
Overall Status
Completed
CT.gov ID
NCT00244088
Collaborator
(none)
340
8
Study Details
Study Description
Brief Summary
The aim of this study is to define the etiology of intra-abdominal infections, to study the role of Enterococcus spp and Pseudomonas aeruginosa in these infections and to clarify the need for specific enterococcal antimicrobial coverage.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Study of the Etiology of Intra-Abdominal Infections
Study Start Date
:
Apr 1, 2004
Actual Primary Completion Date
:
Dec 1, 2004
Actual Study Completion Date
:
Dec 1, 2004
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
A case will be defined as an intra-abdominal abscess or peritoneal fluid culture that will be positive for enterococcus or an enterococcal bacteriemia in association with an intra-abdominal source of infection.
-
A control will be defined as a culture-positive intra-abdominal infection or bacteriemia due to an intraabdominal focus where enterococci have not been isolated.
Exclusion Criteria:
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Wyeth is now a wholly owned subsidiary of Pfizer
Investigators
- Principal Investigator: Medical Monitor, Wyeth is now a wholly owned subsidiary of Pfizer
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00244088
Other Study ID Numbers:
- 101316
First Posted:
Oct 25, 2005
Last Update Posted:
Sep 1, 2009
Last Verified:
Aug 1, 2009
Keywords provided by ,
,
Additional relevant MeSH terms: